Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial

Abstract The effects of intravenous sedation with midazolam on the cerebral function of elderly patients with severe dementia are unclear. This study aimed to evaluate its effects on parameters such as brainwaves and cerebral blood flow (CBF) and compare them between elderly individuals with dementi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuichi Tatsuno, Yoshinari Morimoto, Megumi Hayashi, Takatoshi Iida
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/14cd0029bf184bb3a575bee0f1375159
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:14cd0029bf184bb3a575bee0f1375159
record_format dspace
spelling oai:doaj.org-article:14cd0029bf184bb3a575bee0f13751592021-12-02T12:09:26ZComparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial10.1038/s41598-021-83122-22045-2322https://doaj.org/article/14cd0029bf184bb3a575bee0f13751592021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83122-2https://doaj.org/toc/2045-2322Abstract The effects of intravenous sedation with midazolam on the cerebral function of elderly patients with severe dementia are unclear. This study aimed to evaluate its effects on parameters such as brainwaves and cerebral blood flow (CBF) and compare them between elderly individuals with dementia and without cognitive impairment. Ten patients with severe dementia and 10 without cognitive impairment were registered. The bispectral index (BIS) and normalized tissue hemoglobin index (nTHI), which reflects CBF using near-infrared spectroscopy, were measured. Midazolam was administered until a Modified Observer’s Assessment of Alertness/Sedation score of 2 was reached. The chi-squared, Mann–Whitney U, Wilcoxon signed-rank, and Friedman tests and multiple regression analysis were used for comparisons. Whereas a similar decline in BIS values was observed in both groups after midazolam administration (P < 0.018), there was a significant decrease by 9% in the nTHI of the dementia-positive group (P < 0.013). However, there was no significant difference in the nTHI between the dementia-positive and dementia-negative group according to the multiple regression analysis (P = 0.058). In the dementia-negative group, none of the measured values differed from the baseline values. In the dementia-positive group, sedation with midazolam resulted in a 9% decrease in the CBF.Yuichi TatsunoYoshinari MorimotoMegumi HayashiTakatoshi IidaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yuichi Tatsuno
Yoshinari Morimoto
Megumi Hayashi
Takatoshi Iida
Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
description Abstract The effects of intravenous sedation with midazolam on the cerebral function of elderly patients with severe dementia are unclear. This study aimed to evaluate its effects on parameters such as brainwaves and cerebral blood flow (CBF) and compare them between elderly individuals with dementia and without cognitive impairment. Ten patients with severe dementia and 10 without cognitive impairment were registered. The bispectral index (BIS) and normalized tissue hemoglobin index (nTHI), which reflects CBF using near-infrared spectroscopy, were measured. Midazolam was administered until a Modified Observer’s Assessment of Alertness/Sedation score of 2 was reached. The chi-squared, Mann–Whitney U, Wilcoxon signed-rank, and Friedman tests and multiple regression analysis were used for comparisons. Whereas a similar decline in BIS values was observed in both groups after midazolam administration (P < 0.018), there was a significant decrease by 9% in the nTHI of the dementia-positive group (P < 0.013). However, there was no significant difference in the nTHI between the dementia-positive and dementia-negative group according to the multiple regression analysis (P = 0.058). In the dementia-negative group, none of the measured values differed from the baseline values. In the dementia-positive group, sedation with midazolam resulted in a 9% decrease in the CBF.
format article
author Yuichi Tatsuno
Yoshinari Morimoto
Megumi Hayashi
Takatoshi Iida
author_facet Yuichi Tatsuno
Yoshinari Morimoto
Megumi Hayashi
Takatoshi Iida
author_sort Yuichi Tatsuno
title Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_short Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_full Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_fullStr Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_full_unstemmed Comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
title_sort comparison of intravenous sedation using midazolam during dental treatment in elderly patients with/without dementia: a prospective, controlled clinical trial
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/14cd0029bf184bb3a575bee0f1375159
work_keys_str_mv AT yuichitatsuno comparisonofintravenoussedationusingmidazolamduringdentaltreatmentinelderlypatientswithwithoutdementiaaprospectivecontrolledclinicaltrial
AT yoshinarimorimoto comparisonofintravenoussedationusingmidazolamduringdentaltreatmentinelderlypatientswithwithoutdementiaaprospectivecontrolledclinicaltrial
AT megumihayashi comparisonofintravenoussedationusingmidazolamduringdentaltreatmentinelderlypatientswithwithoutdementiaaprospectivecontrolledclinicaltrial
AT takatoshiiida comparisonofintravenoussedationusingmidazolamduringdentaltreatmentinelderlypatientswithwithoutdementiaaprospectivecontrolledclinicaltrial
_version_ 1718394614659940352